BreathEaseX: Three Months of Daily Measurements
Daily data rather than impressions, including the weeks where everything got worse for unrelated reasons.
Peter S.
What measurable changes does BreathEaseX produce?
Individual results vary and no supplement guarantees outcomes. Users who track objectively most commonly report improvements in recovery time after fixed exertion and reductions in morning cough frequency. Peak flow changes are less consistently reported. Day-to-day variation from sleep, air quality and illness is substantial, so weekly averages are more informative than single readings.
What I measured and how
Peak flow: a $25 meter, three readings each morning, best of three, same time daily.
Recovery time: seconds to normal breathing after one specific flight of twenty-two stairs, measured every Sunday morning.
Morning cough: yes or no, plus rough duration.
Confounders logged daily: hours slept, local air quality index, any illness, alcohol the previous evening.
Two weeks of baseline before the first dose. Ninety days on the product.
Recovery time, weekly averages
| Period | Recovery (sec) | Notes |
|---|---|---|
| Baseline (2 wks) | 97 | — |
| Weeks 1–2 | 94 | Within noise |
| Weeks 3–4 | 86 | First clear movement |
| Weeks 5–6 | 73 | Largest change |
| Weeks 7–8 | 88 | Head cold, week 7 |
| Weeks 9–10 | 70 | Recovered |
| Weeks 11–12 | 81 | Poor air quality, 6 days |
| Week 13 | 69 | Plateau |
The two spikes are a head cold and an air quality event. Without the confounder log I would have read those as the product failing.
Peak flow was less informative
Baseline average 512 L/min. Week 13 average 531 L/min.
That is a small change, and daily variation was substantial — readings ranged from 470 to 555 across the period depending mostly on sleep and time of day.
Peak flow measures how fast you can force air out, which reflects airway calibre. It moved slightly in the right direction and I would not claim it as a clear result. The technique also improves with practice, which confounds early readings upward independently of anything else.
If you can only track one thing, track recovery time. It was far more responsive.
Track it properly if you want a real answer
Set a baseline before your first dose and compare weekly averages, not individual days.
Morning cough
Baseline: cough on 13 of 14 mornings, typically eight to twelve minutes.
Weeks 1–2: 12 of 14, and slightly longer — the expected early increase.
Weeks 5–6: 6 of 14, typically under three minutes.
Weeks 11–13: 4 of 21, typically under two minutes.
This was the clearest and most consistent change of anything I measured.
What the confounder log taught me
More than the primary measurements did, in some ways.
Sleep under six hours reliably added ten to fifteen seconds to my recovery time the next morning, independent of everything else.
The six days of poor air quality in week eleven degraded every measure I was taking, and they recovered afterward.
The head cold in week seven set everything back for about ten days.
Without logging these I would have concluded the product stopped working twice. Anyone tracking results needs to log what else is happening, or the noise will produce false conclusions in both directions.
The plateau, visible in the data
Between week six and week thirteen, excluding the confounded periods, recovery time held between 69 and 73 seconds.
The curve is clearly asymptotic. Whatever this does, it had finished doing it by around week six and then maintained.
That is consistent with everything else I have read from longer-term users and it is the expectation to set.
Pros and cons
What worked
- Recovery time improved from 97 to around 70 seconds
- Morning cough dropped from 13 of 14 mornings to 4 of 21
- Effects held steadily through week thirteen
- Data responded appropriately to illness and air quality events
What did not
- Peak flow barely moved, which was my most objective measure
- Improvement stopped entirely after around week six
- Daily variation is large enough to mislead without weekly averaging
- Unblinded single-person data proves nothing generalisable
The verdict
Ninety days of daily data showed a clear improvement in recovery time from 97 to around 70 seconds and a substantial reduction in morning cough, with effects plateauing around week six. Peak flow moved little. The confounder log was essential — two illness and air quality events would have looked like the product failing without it. This is one unblinded person's data and proves nothing generalisable, but the pattern matches the reported mechanism closely.
